Jacobs Levy Equity Management, Inc Spring Works Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$65.1 - $93.59 $673,068 - $967,627	-10,339 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$48.36 - $77.92 $57,500 - $92,646	-1,189 Reduced 10.31%	10,339 $750,000
Q3 2020 Nov 16, 2020	BUY	$36.14 - $51.99 $416,621 - $599,340	11,528 New	11,528 $550,000

240

69.7M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.51B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.